Evaluation of novel radiopharmaceutical compounds for radiodiagnostics and radiotherapy


The Radiochemical Studies Laboratory has signed an agreement for the provision of scientific services to the German company ITM Medical Isotopes GmbH, for the implementation of the program entitled: “Non-clinical evaluation of a series of novel radiopharmaceutical compounds targeting oncologic and cardiovascular disease”. Within the framework of this agreement, the Laboratory focuses on the in vitro and in vivo pre-clinical evaluation of new radiopharmaceuticals for molecular imaging and radioisotope therapy.

INRASTES - Official Web Site
Skip to content